Eukarys
Eukarÿs develops C3P3 artificial expression system for synthetic gene therapy and bioproduction
back to Directory
Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.
Eukarÿs develops C3P3 artificial expression system for synthetic gene therapy and bioproduction